bluebird bio is a biotechnology company engaged in researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases and cancer. The company has built a product platform with a range of therapeutic potential in a variety of indications based on its lentiviral gene addition platform, gene editing and cancer immunotherapy capabilities. The company is developing LentiGlobin gene therapy for sickle cell disease; Lenti-D gene therapy for cerebral adrenoleukodystrophy; and in collaboration with Bristol-Myers Squibb, the company is developing bb2121 (idecabtagene vicleucel) and bb21217 product candidates as treatments for multiple myeloma.

Camping World Holdings is a holding company. Through its subsidiaries, the company is a retailer of recreational vehicles (RVs) and RV-related products and services, and a retailer of outdoor lifestyle and active sports-related products and services. The company's segments include: consumer services and plans, which provides extended vehicle service contracts, emergency roadside assistance, property and casualty insurance programs, membership clubs, vehicle financing and refinancing, travel protection, and co-branded credit cards; dealership, which provides new vehicles and used vehicles; and retail, which includes: RV supply and maintenance products, and outdoor equipment and recreational products.

Charles & Colvard manufactures, markets, and distributes Charles & Colvard Created Moissanite? (which the company refers to as moissanite or moissanite jewels) and finished jewelry featuring its proprietary moissanite gemstone for sale in the worldwide jewelry market. The company sells loose moissanite jewels and finished jewelry through various operating segments: its Online Channels segment, which comprises its charlesandcolvard.com website, e-commerce outlets, including marketplaces, drop-ship customers, and other e-commerce customers; and its Traditional segment, which consists of domestic and international distributors and retail customers.

Dynex Capital is an internally managed mortgage real estate investment trust, which primarily invests in residential and commercial mortgage-backed securities (MBS) on a leveraged basis. The company's investments consist principally of Agency and non-Agency MBS including residential MBS, commercial MBS (CMBS) and CMBS interest-only (IO) securities. Agency MBS have a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity (GSE). Non-Agency MBS are issued by non-governmental enterprises and do not have a guaranty of principal payment. CMBS IO securities in which the company invests may be issued by a GSE or a non-governmental enterprise.

Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing the company's patented piezo-print delivery technology, branded the Optejet?. The company's MicroStat is a fixed combination formulation of phenylephrine-tropicamide for mydriasis (pupil dilation). MicroPine is a topical therapy for the treatment of progressive myopia. MicroProst is a latanoprost formulation for lowering intraocular pressure in patients with ocular hypertension, primary open angle glaucoma, and chronic angle closure glaucoma. MicroTears is the company's over-the-counter product candidate for hyperemia (red eye), pruritis (itch) and dry eye.

Fastenal is engaged in the wholesale distribution of industrial and construction supplies. The company is a distributor of fasteners and related industrial and construction supplies. This includes threaded fasteners, bolts, nuts, screws, studs, and related washers, as well as miscellaneous supplies and hardware, such as pins, machinery keys, concrete anchors, metal framing systems, wire rope, strut, rivets, and related accessories. The company's fastener product line is primarily sold under the Fastenal product name.

Gaia operates a global digital video subscription service and on-line community. The company's subscribers have access to a library of films, documentaries, interviews, yoga classes, transformation-related content, and majority of which are available to its subscribers for digital streaming. The company's network includes the following channels: Yoga, which provides access to streaming yoga, Eastern arts, and other movement-based classes; Transformation and Alternative Healing, which features content in the areas of alternative and integrative medicines, holistic healing, longevity, spiritual growth and consciousness; and Seeking Truth, which provides perspectives for today's changing world.

Horizon Technology Finance is a finance company that lends to and invests in development-stage companies in the technology, life science, healthcare information and services and cleantech industries (collectively, Target Industries). The company focuses on making secured debt investments to venture capital backed companies in its Target Industries. The company is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company. The company also has elected to be treated as a regulated investment company. The company's investment activities, and its day-to-day operations, are managed by its advisor, Horizon Technology Finance Management LLC.

Mohawk is a holding company. Through its subsidiaries, the company is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing, and data analytics to design, develop, market and sell products. The company offers kitchen sets, beauty tools, home appliances, and other related items. The company predominately operates through online retail channels such as Amazon, eBay, and Walmart.

Opiant Pharmaceuticals is a pharmaceutical company developing medicines for addictions and drug overdose. The company has developed NARCAN? (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder, Opioid Use Disorder, and Acute Cannabinoid Overdose. The company's principal products include OPNT003 - Intranasal Nalmefene for OOR; OPNT001 - Intranasal Naloxone for Eating Disorders; OPNT002 - Nasal Naltrexone for Alcohol Use Disorder; and OPNT004 - Drinabant Injection for Acute Cannabinoid Overdose.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.